2022 Conference Publication Immunoregulatory role for complement receptors in murine breast cancerRolfe, Barbara, Sonderegger, Stefan, McGirr, Crystal and Woodruff, Trent (2022). Immunoregulatory role for complement receptors in murine breast cancer. 28th Virtual International Complement Workshop (ICW) of the International-Complement-Society (ICS), Virtual, 6-10 December 2021. Oxford, United Kingdom: Elsevier. |
2019 Conference Publication Complement C5a receptors, C5aR1 and C5aR2, mediate opposing pathologies in a mouse model of melanomaNabizadeh, J., Manthey, H., Panagides, N., Steyn, F., Lee, J., Li, X., Woodruff, T. and Rolfe, B. (2019). Complement C5a receptors, C5aR1 and C5aR2, mediate opposing pathologies in a mouse model of melanoma. 17th International Congress of Immunology (IUIS), Beijing, China, 19-23 October 2019. Weinheim, Germany: Wiley. |
2018 Conference Publication High F-Content Perfluoropolyether-based Polymers for Targeted Detection of Breast Cancer by 19F Magnetic Resonance and Optical ImagingZhang, Cheng, Moonshi, Shehzahdi Shebbrin, Ta, Hang T., Han, Yanxiao, Han, Felicity Y., Peng, Hui, Král, Petr, Rolfe, Barbara E. and Whittaker, Andrew K. (2018). High F-Content Perfluoropolyether-based Polymers for Targeted Detection of Breast Cancer by 19F Magnetic Resonance and Optical Imaging. World Polymer Congress Macro 2018, Cairns QLD Australia, 1-5 July 2018. |
2010 Conference Publication Effect of hydrogels or lipoxinA4 on rat periodontal fibroblasts in-vitroVaranasi, S., Wang, D., Peng, H., Do, H.L., Smid, J., Rolfe, B., Rasoul, F., Whittaker, A.K. and Symons, A. (2010). Effect of hydrogels or lipoxinA4 on rat periodontal fibroblasts in-vitro. Australian/New Zealand Division Golden Jubilee Meeting, Sebel Harbourside Hotel, Kiama, New South Wales, Australia,, September 27-29 2010. |
2008 Conference Publication Protective effects of C5a receptor antagonism in a mouse model of atherosclerosisManthey, Helga, Thomas, Anita, Taylor, Stephen, Woodruff, Trent, Moore, Tyson, Shiels, Ian and Rolfe, Barbara (2008). Protective effects of C5a receptor antagonism in a mouse model of atherosclerosis. ICW Basel, XXII International Complement Workshop, Basel, Switzerland, 28 September - 2 October 2008. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.molimm.2008.08.167 |
2007 Conference Publication Does C5a have a role in the pathophysiology of atherosclerosis?Manthey, H., Taylor, S., Shiels, I. and Rolfe, B. (2007). Does C5a have a role in the pathophysiology of atherosclerosis?. XXI International Complement Workshop, Beijing, China, 22-26 October 2006. Oxford, United Kingdom: Pergamon. doi: 10.1016/j.molimm.2006.07.154 |
2007 Conference Publication Inhibition of myofibroblast differentiation by silencing transforming growth factor beta receptorChau, Yu-Qian, Zhang, Bing, Rolfe, Barbara, Wei, Ming and Campbell, Julie (2007). Inhibition of myofibroblast differentiation by silencing transforming growth factor beta receptor. Annual Congress of the European Society of Gene and Cell Therapy, De Doelen, Rotterdam, The Netherlands, 27-30 October, 2007. NEW ROCHELLE: MARY ANN LIEBERT INC. |
2007 Conference Publication Surface protein regulators of rat bone marrow-derived mesenchymal stem cell morphologyClark, Sharon F., Cao, Yang, Croll, Tristan, Jahnke, Sani, Dyne, Al, Rolfe, Barbara, Brooke, Gary, Atkinson, Kerry, Campbell, Julie and Cooper-White, Justin (2007). Surface protein regulators of rat bone marrow-derived mesenchymal stem cell morphology. International Society for Stem Cell Research (ISSCR) Annual Meeting, Cairns, Qld, Australia, 17-20 June, 2007. |
2006 Conference Publication The peritoneal cavity as a bioreactor for tissue engineered arteriesCampbell, Julie H., Mooney, Jane, Le, Sarah, Walker, Philip, Zhang, Bing, Rolfe, Barbara and Campbell, Gordon R. (2006). The peritoneal cavity as a bioreactor for tissue engineered arteries. XIVth International Vascular Biology Meeting, Noordwijkerhout, Netherlands, 6-10 June 2006. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.vph.2006.08.128 |
2005 Conference Publication Artifical arteries from cells of bone marrow originCampbell, J. H., Efendy, J., Chue, W., Daly, C., Mooney, J., Zhang, B., Rolfe, B., Walker, P. and Campbell, G. R. (2005). Artifical arteries from cells of bone marrow origin. Vascular 2005, Sydney, 9-14 Sep, 2005. |
2004 Conference Publication Rho and smooth muscle cell phenotypeWorth, N.F., Rolfe, B.E., Campbell, J.H. and Campbell, G.R. (2004). Rho and smooth muscle cell phenotype. Thirteenth International Symposium on Atherosclerosis, Kyoto, Japan, 27 September - 3 October 2003. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S0531-5131(03)01863-6 |
2003 Conference Publication Rho and smooth muscle cell phenotypeWorth, N. F., Rolfe, B. E. and Campbell, G. R. (2003). Rho and smooth muscle cell phenotype. 13th International Atherosclerosis Symposium, Kyoto, Japan, 28 September - 2 October 2004. Amsterdam, The Netherlands: Elsevier. doi: 10.1016/S1567-5688(03)90774-4 |
2001 Conference Publication A role for Rho in smooth muscle phenotypic regulationCampbell, G. R., Worth, N. F. and Rolfe, B. E. (2001). A role for Rho in smooth muscle phenotypic regulation. Australian Vascular Biology Society, Noosa, Queensland, Australia, Ausgust, 2001. New York: The Academy. |
2001 Conference Publication The signal attenuating effects of LIF treated vascular smooth muscle cells as a means of inhibiting hyperplasiaWorld, C., Rolfe, B. E. and Campbell, J. H. (2001). The signal attenuating effects of LIF treated vascular smooth muscle cells as a means of inhibiting hyperplasia. Australian Vascular Biology Society 9th Annual Scientific Meeting, Noosa Qld, 30 August - September 2, 2001. |
2001 Conference Publication Rho as a regulator of smooth muscle phenotypeRolfe, B. E., Worth, N.F. and Campbell, G. R. (2001). Rho as a regulator of smooth muscle phenotype. COMBIO, Canberra, October 2001. |
2001 Conference Publication Attenuation of smooth muscle proliferation by leukaemia inhibitory factor involves the activation of negative feed-back regulatorsWorld, C., Rolfe, B. E. and Campbell, J. H. (2001). Attenuation of smooth muscle proliferation by leukaemia inhibitory factor involves the activation of negative feed-back regulators. COMBIO, Canberra, October 2001. |
2001 Conference Publication A role for Rho in smooth muscle phenotypic regulationWorth, N. F., Campbell, G. R. and Rolfe, B. E. (2001). A role for Rho in smooth muscle phenotypic regulation. 6th Saratoga International Conference on Atherosclerosis, Tokyo, Japan, 3-6 April 2001. Malden, MA United States: Wiley-Blackwell. doi: 10.1111/j.1749-6632.2001.tb03955.x |
2001 Conference Publication Smooth muscle, the cytoskeleton and cell signallingWorth, N.F., Rolfe, B. E. and Campbell, G. R. (2001). Smooth muscle, the cytoskeleton and cell signalling. Australian Vascular Biology Society 9th Scientific Annual Meeting, Noosa, Qld, 30 August - 2 September 2001. |
2000 Conference Publication The role of leukemia inhibitory factor in vascular smooth muscle cell functionWorld, C., Rolfe, B. E. and Campbell, J. H. (2000). The role of leukemia inhibitory factor in vascular smooth muscle cell function. International Congress on Differentiation & Cell Biology, Gold Coast, Australia, 24-28 September 2000. Australia: Magic Touch Pty Ltd. |
2000 Conference Publication A role for Rho in smooth muscle phenotypic regulationWorth, N., Rolfe, B. E., Campbell, G. R. and Campbell, J. H. (2000). A role for Rho in smooth muscle phenotypic regulation. International Congress on Differentiation & Cell Biology, Gold Coast, Australia, 24-28 September 2000. Australia: Magic Touch Pty Ltd. |